期刊
NANOTECHNOLOGY
卷 29, 期 33, 页码 -出版社
IOP PUBLISHING LTD
DOI: 10.1088/1361-6528/aac7a4
关键词
tumor-on-a-chip; nanoparticles; cancer therapy
资金
- National Science and Technology Major Project [2018ZX10732401-003-007]
- National Key Research and Development Program from the Ministry of Science and Technology of the People's Republic of China [2016YFC1101302]
Cancer has become the most prevalent cause of deaths, placing a huge economic and healthcare burden worldwide. Nanoparticles (NPs), as a key component of nanomedicine, provide alternative options for promoting the efficacy of cancer therapy. Current conventional cancer models have limitations in predicting the effects of various cancer treatments. To overcome these limitations, biomimetic and novel 'tumor-on-a-chip' platforms have emerged with other innovative biomedical engineering methods that enable the evaluation of NP-based cancer therapy. In this review, we first describe cancer models for evaluation of NP-based cancer therapy techniques, and then present the latest advances in 'tumor-on-a-chip' platforms that can potentially facilitate clinical translation of NP-based cancer therapies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据